In the News

Visit our e-commerce website for Conferences, Webinars, Medical Membership, eBooks etc [More Details]

Medical Professionals Become an LDN Specialist [More Details]

LDN Articles from general news sources

Got Inflammation? How LDN can help in the times of Covid-19 (News)
Read More
Nonopioid Analgesic, Nonpharmacologic Options for Pain Management Reviewed (News)
Read More
Low-Dose Naltrexone (LDN) for Mood Regulation and Immunomodulation in ASD News)
Read More
LDN And Rheumatoid Arthritis (News)
Read More
Research roundup: Recent grants and publications for Emory faculty and staff (News)
Read More
‘Promising Results’ for Low-Dose Naltrexone as Pain Reliever (News)
Read More
AgelessRx Launches Pilot Post-COVID Clinical Trial Using LDN and NAD (News)
Read More
Statera Biopharma and Immune Therapeutics Inc. Announce Strategic Agreement for Rights to Low Dose Naltrexone (News)
Read More
Yukon government releases webpage with resources on long COVID (News)
Read More
Scientists get first look at T cell responses in Ebola virus survivors (News)
Read More
How Chronic Pain Can Lead to Autoimmunity Problems (News)
Read More
Naltrekson ograniczył ból związany z zespołem piekących ust (News)
Read More
Fibromyalgia Year in Review: 2022 (News)
Read More
McLaughlin leads research on identifying minimally invasive biomarkers for MS (News)
Read More
What is the evidence behind potential Low Dose Naltrexone benefits? (News)
Read More
Chronic fatigue: Drug addiction medicine Naltrexone could treat condition (News)
Read More
How Long Does it Take Low Dose Naltrexone to Work? (News)
Read More
Halberd Corp. Develops Medication to Boost Immune System Against SARS-CoV-2 (Covid-19) (News)
Read More
Low-Dose Naltrexone for Autoimmune and Chronic Pain Conditions, Podcast Interview (News)
Read More
Low-dose naltrexone (LDN) hope for patients with longCOVID syndrome? (News)
Read More
Low-Dose Naltrexone Used as Alternative to Opioids for Chronic Pain Patients (News)
Read More
Data from First Phase III Clinical Study of PXT3003 in Charcot-Marie-Tooth Disease Type 1A... (News)
Read More
Low Dose Naltrexone (LDN) Provides Surprising Pain Relief (News)
Read More
Calls for the radical treatment (News)
Read More
Research suggests toll-like receptor 4 appears to play role in severe COVID (News)
Read More
Hot Topic - Low Dose Naltrexone treatment has proven to help with COVID 19 and Long COVID in The LDN Book 3 (News)
Read More
Low-Dose Naltrexone May Be Opioid Replacement for Chronic Pain (News)
Read More
New research gives hope to COVID-19 long haul carriers (News)
Read More
Addiction drug shows promise lifting long COVID brain fog, fatigue (News)
Read More
Low Dose Naltrexone Emerging as Treatment for Intractable Pain (News)
Read More
Repurposing low-dose naltrexone (LDN) for the prevention and treatment of immunothrombosis in COVID-19 (News)
Read More
Long COVID Is Common and Scary! (News)
Read More
Study of Immunomodulation Using Naltrexone and Ketamine for COVID-19 (Study)
Read More
Dry eye research reveals impact of disease, potential new treatments (News)
Read More
LDN for Treating Spike Protein Injuries, Diseases (News)
Read More
Medicine specialist talks treatments for lingering COVID-19 symptoms (News)
Read More
How a Drug for Opioid and Alcohol Addiction Is Helping Treat Long COVID (News)
Read More
Doctor Shares Alternative Spike Protein Treatments When Go-to Options Fail (News)
Read More
Addiction Medication Promising for Chronic, Refractory Pain (News)
Read More
Discussing Low-Dose Naltrexone with Sajad Zalzala (News)
Read More
It’s time for a reckoning in pain medicine (News)
Read More
Low-dose naltrexone safe, effective for neuropathic corneal pain (News)
Read More